Chong Kun Dang Pharmaceutical Corp
KRX:185750
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chong Kun Dang Pharmaceutical Corp
KRX:185750
|
KR |
|
F
|
Freeport-McMoRan Inc
LSE:0R2O
|
US |
|
Crystal Clear Electronic Material Co Ltd
SZSE:300655
|
CN |
|
Reckitt Benckiser Group PLC
OTC:RBGPD
|
UK |
|
L
|
Legrand SA
XBER:LRC
|
FR |
|
Green Cross Holdings
KRX:005250
|
KR |
|
D
|
De La Rue PLC
DUS:DL1C
|
UK |
|
S
|
Seabridge Gold Inc
XMUN:SRM
|
CA |
|
M
|
Meiji Holdings Co Ltd
DUS:3M0
|
JP |
|
B
|
Bradda Head Lithium Limited
F:8CD1
|
IM |
Wall St Price Targets
Price Targets Summary
Chong Kun Dang Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for
Chong Kun Dang Pharmaceutical Corp is 120 214.29 KRW with a low forecast of 101 000 KRW and a high forecast of 162 750 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Chong Kun Dang Pharmaceutical Corp's stock price target?
Price Target
120 214.29
KRW
According to Wall Street analysts, the average 1-year price target for
Chong Kun Dang Pharmaceutical Corp is 120 214.29 KRW with a low forecast of 101 000 KRW and a high forecast of 162 750 KRW.
What is the Revenue forecast for Chong Kun Dang Pharmaceutical Corp?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Chong Kun Dang Pharmaceutical Corp?
Projected CAGR
7%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 2 years is 7%.
What is the Operating Income forecast for Chong Kun Dang Pharmaceutical Corp?
Projected CAGR
3%
Over the last 10 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 2 years is 3%.
What is the Pre-Tax Income forecast for Chong Kun Dang Pharmaceutical Corp?
Projected CAGR
7%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 2 years is 7%.
What is the Net Income forecast for Chong Kun Dang Pharmaceutical Corp?
Projected CAGR
3%
The compound annual growth rate for Net Income over the next 2 years is 3%.